Champions Oncology
(NASDAQ) CSBR
Champions Oncology Financials at a Glance
Market Cap
$80.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$57.94M
Net Income (TTM)
-$2.28M
EPS (TTM)
-$0.17
P/E Ratio
-34.93
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Price
$6.00
Volume
225
Open
$5.89
Price
$6.00
Volume
225
Open
$5.89
Previous Close
$6.00
Daily Range
$5.70 - $6.00
52-Week Range
$5.50 - $8.74
Estimated Earnings Date
Jul 16, 2026
Dividend
$0.00
Beta (Volatility)
0.38 (Low)
Price
$6.00
Volume
225
Open
$5.89
Previous Close
$6.00
Daily Range
$5.70 - $6.00
52-Week Range
$5.50 - $8.74
Estimated Earnings Date
Jul 16, 2026
CSBR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Champions Oncology
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
213
CEO
Robert Brainin
Website
www.championsoncology.comHeadquarters
Hackensack, NJ 07601, US
CSBR Financials
Key Financial Metrics (TTM)
Gross Margin
45.88%
Operating Margin
-3.84%
Net Income Margin
-3.94%
Return on Equity
-57.99%
Return on Capital
49.06%
Return on Assets
-8.02%
Earnings Yield
-2.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$80.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
13.89M
Volume
225
Avg. Volume
8.33K
Financials (TTM)
Gross Profit
$26.58M
Operating Income
-$2.22M
EBITDA
-$948.00K
Operating Cash Flow
$4.39M
Capital Expenditure
-$578.00K
Free Cash Flow
$3.82M
Cash & ST Invst.
$7.13M
Total Debt
$5.00M
Champions Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.56M
-2.8%
Gross Profit
$7.73M
-25.9%
Gross Margin
46.65%
N/A
Market Cap
$80.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$384.86K
N/A
Employees
210
N/A
Net Income
-$279.00K
-106.2%
EBITDA
$104.00K
-97.9%
Quarterly Fundamentals
Total Cash
$7.13M
+122.6%
Total Debt
$5.00M
-22.3%
Accounts Receivable
$12.07M
-23.5%
Inventory
$0.00
N/A
Long Term Debt
$3.39M
-32.2%
Short Term Debt
$1.61M
+12.1%
Return on Assets
-8.02%
N/A
Return on Invested Capital
-28.61%
N/A
Free Cash Flow
-$1.38M
-407.1%
Operating Cash Flow
-$1.34M
-373.3%